Urologic DiseasesPaprikaNCT04190719
Patient Empowerment for Major Surgery Preparation @ Home
A study testing multimodal prehabilitation in people with Urologic Diseases and Cardiovascular Diseases, run by University Hospital, Grenoble at 1 site in France.
Trial summary
Non-randomized monocentric open cohort study vs historical comparative group testing the efficacy of a multimodal prehabilitation program (based on physical activity, nutritional support and mental preparation) for unfit patients based on nutrition, physical activity and mental preparation in reducing postoperative… Read more about this study
- Who is it for?
- Ages 18 to 99 years
- Conditions the study is for
- Urologic Diseases, Cardiovascular Diseases, Thoracic Diseases
- What is being tested?
- multimodal prehabilitation
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 225 participants
- Where
- 1 siteFrance
- Study dates
- 3 Jan 2020to 31 Dec 2021
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 99 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Patient eligible to elective major surgery (digestive, orthopedic, vascular-thoracic, urologic)
- Age > 70 years and/or American Society of Anesthesiologists (ASA) score 3-4
- or Unfit patient according to appropriate scores (Two among 3 scores (HAD, Physical activity score, nutritional score) below threshold). Unfit patients will be defined by at least 2 criteria if 'YES' answers: Physical activity: Less than 50% of WHO recommendations = less than 5000 steps/day or less than 75 min moderate activity/week or less than 12 min moderate activity/day Yes/No Malnutrition: BMI < 20 kg/m2 if < 70 years (or <22 if >70y) = undernutrition Yes/No or BMI>25 kg/m2 (= overweight to obesity) or Loss of appetite? Mental evaluation HAD (Hospital Anxiety and Depression) >8 for A or D score Yes/No
- Diagnosis:
- Elective major surgery (digestive, orthopedic, vascular-thoracic, urologic)
- Regulatory aspects: Be legally able to give consent Patient affiliated to social security
Who cannot join
- Planned surgery (less than 4 weeks at inclusion)
- Urgent surgery
- Patient with, at baseline, good to excellent physical, nutritional, mental status as defined by appropriate scores.
- Patient considered not eligible to this program for physical or psychological reasons by the surgeon or the anesthetist
- Persons referred in Articles L1121-5 to L1121-8 of the French code of public health (this corresponds to all persons protected: pregnant or parturient women, breastfeeding mothers, persons deprived of liberty by judicial or administrative decision, persons subject to a legal protection measure).
Trial locations and contacts
1 site in 1 country.
Laura Albaladejo contact
France1 site, 1 recruiting
- Recruiting
Centre Hospitalier Universitaire Grenoble Alpes
La Tronche, 38700
Marie-France Vaillant, +33 4 76 76 89 13, mfvaillant@chu-grenoble.fr
Laura Albaladejo, EXT-LAlbaladejo@chu-grenoble.fr
About this study
Official title: Patient Empowerment for Major Surgery Preparation @ Home: Multimodal Prehabilitation in Major Elective Surgery
Non-randomized monocentric open cohort study vs historical comparative group testing the efficacy of a multimodal prehabilitation program (based on physical activity, nutritional support and mental preparation) for unfit patients based on nutrition, physical activity and mental preparation in reducing postoperative complications in elective major surgery
Read the detailed description
Prehabilitation programs essentially based on physical activity improvement may reduce postoperative complications after major surgery. We hypothesize that a multimodal program based on physical activity, nutritional support and mental preparation may not only improve postoperative recovery and reduce costs but also improve health status beyond postoperative period.
Non-randomized monocentric open cohort study vs historical comparative group testing the efficacy of a multimodal prehabilitation program for unfit patients based on nutrition, physical activity and mental preparation in reducing postoperative complications in elective major surgery.
Other outcomes will be measured : length of hospital stay, hospital readmissions, direct costs, health status at 1 and 6 months.
Moreover, the feasibility and adherence of Paprika program will be evaluated. Inter-data centres relating to the implementation of the same prehabilitation program will be compared with the consortium Paprika (Hospital Clinic of Barcelona, University of Cologne, University of Gdansk)
- Conditions
- Urologic Diseases, Cardiovascular Diseases, Thoracic Diseases, Orthopedic Disorder, Gastrointestinal Disease
- Being tested
- multimodal prehabilitation
- Medical subject headings
- Urologic Diseases, Cardiovascular Diseases, Thoracic Diseases, Musculoskeletal Diseases, Gastrointestinal Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
multimodal prehabilitationOther
Paprika prehabilitation program content: patients will have choices for each activity. Messages and motivation will be reinforced by using a mobile app or leaflet advices, according to patient's preferences.
- Physical activity promotion by discovering ebike, personalised gymnastics and encouragement to increase the number of daily steps of patients, measured by a wristband and a mobile App
- An individualized nutritional optimization plan with dietary advices and protein supplementation (if necessary).
- Psychological support will be proposed through auto-hypnosis sensibilisation or management of stress with Cognitive Behavior Stress Management technics
| Study group | Role | What they receive |
|---|---|---|
| Paprika group | Experimental | Patients coming for elective major surgery will participate to Paprika program Receives: Other: multimodal prehabilitation |
| Historical group | No intervention | Patients previously operated with same characteristics |
What is being measured
The primary outcome is the main question the study is designed to answer.
Rate of postoperative complications at Day-30
Rate of postoperative complications at Day-30 classified following the standards of the European Society of Anaesthesiology and European Society of intensive Care Medicine.
Measured: at Day-30 post surgery
Secondary outcomes (10)
Number and severity of postoperative complications
Number and severity of postoperative complications using Dindo-Clavien classification within 30 days
Measured: within 30 days post surgery
Length of stay (ICU and Hospital)
Length of ICU stay and Length of hospital stay
Measured: within 30 days post surgery
Hospital readmission
Hospital readmission within 30 days
Measured: within 30 days post surgery
Direct cost
Valuation in euros of the direct cost from a 1-month hospital point of view (duration and type of stay, acts, GHM...) by integrating for the intervention group the cost of the pre-habilitation program. Care consumption at 6 months from a social security perspective (Probabilistic Matching National Health Data System)--> comparison of direct costs for the Prehab sessions (professional caregivers and materials costs) versus complication costs of control group
Measured: interventional group: 1 month-cost before surgery+1 month-post surgery / Control group: 1 month-cost post-surgery
Physical activity health status
Health status based on physical activity score:GPAQ and DASI scores
Measured: a baseline, presurgery and 6 months post surgery
Nutritional health status
Nutritional health status based on weight, appetite and ingesta measurements
Measured: at baseline, 1 month and 6 months
Psychological health status
Psychological health status based on HAD, Perceived Stress Scale scores
Measured: at baseline, 1 month and 6 months
Number of patient participation to program in relation to the number of eligible patients
Number of patient participation to program in relation to the number of eligible patients to assess faisability
Measured: During Paprika inclusion period
Ratio patient participation to each session
Ratio patient participation to each session to assess faisability and limitation to participation
Measured: During Paprika 1 month-sessions
Comparison with other centers
Comparison will be done with other cohorts using Paprika program (Barcelona, Gdansk and Köln) on common outcomes
Measured: through study completion, an average of 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Dec 2019
- Study start3 Jan 2020
- Primary completion30 Sep 2021 (estimated)
- Study completion31 Dec 2021 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Urologic DiseasesStudies of the same condition, open and under way.
- More trials run by University Hospital, GrenobleThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Model description
- Interventional group: Patients with Paprika program Historical group: Patients with same characteristics operated in 2018-2019
- Masking
- None (open label)
- Enrolment
- 225 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University Hospital, Grenoble
- Sponsor type
- University, hospital or other
- Collaborators
- EIT Health, Hospital Clinic of Barcelona, Universitätsklinikum Köln, University Clinical Centre, Gdansk
- Responsible party
- Sponsor
- Investigators
- Pierre Albaladejo, Prof., Principal investigator, CHU Grenoble Alpes
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04190719
- Sponsor's protocol ID
- 38RC19.182
- Acronym
- Paprika
- Status last verified
- Nov 2020
- First submitted
- 3 Dec 2019
- Last updated
- 30 Apr 2021
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Anonymised data will be shared with Barcelona, Köln and Gdansk: all collected IPD
Publications
Barberan-Garcia A, Ubre M, Roca J, Lacy AM, Burgos F, Risco R, Momblan D, Balust J, Blanco I, Martinez-Palli G. Personalised Prehabilitation in High-risk Patients Undergoing Elective Major Abdominal Surgery: A Randomized Blinded Controlled Trial. Ann Surg. 2018 Jan;267(1):50-56. doi: 10.1097/SLA.0000000000002293.
PubMed 28489682Barberan-Garcia A, Ubre M, Pascual-Argente N, Risco R, Faner J, Balust J, Lacy AM, Puig-Junoy J, Roca J, Martinez-Palli G. Post-discharge impact and cost-consequence analysis of prehabilitation in high-risk patients undergoing major abdominal surgery: secondary results from a randomised controlled trial. Br J Anaesth. 2019 Oct;123(4):450-456. doi: 10.1016/j.bja.2019.05.032. Epub 2019 Jun 25.
PubMed 31248644
Study at a glance
From the registry record, last updated by the sponsor on 30 Apr 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Patient Empowerment for Major Surgery Preparation @ Home: Multimodal Prehabilitation in Major Elective Surgery
- ClinicalTrials.gov ID
- NCT04190719
- Acronym / sponsor ID
- Paprika / 38RC19.182
- Conditions
- Urologic Diseases, Cardiovascular Diseases, Thoracic Diseases, Orthopedic Disorder, Gastrointestinal Disease
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 225 participants (estimated)
- Lead sponsor
- University Hospital, GrenobleUniversity, hospital or other
- Collaborators
- EIT Health, Hospital Clinic of Barcelona, Universitätsklinikum Köln, University Clinical Centre, Gdansk
- Study start
- 3 Jan 2020 (actual)
- Primary completion
- 30 Sep 2021 (estimated)
- Study completion
- 31 Dec 2021 (estimated)
- First posted
- 9 Dec 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Non-randomized monocentric open cohort study vs historical comparative group testing the efficacy of a multimodal prehabilitation program (based on physical activity, nutritional support and mental preparation) for unfit patients based on nutrition, physical activity and mental preparation in reducing postoperative complications in elective major surgery
Detailed description
Prehabilitation programs essentially based on physical activity improvement may reduce postoperative complications after major surgery. We hypothesize that a multimodal program based on physical activity, nutritional support and mental preparation may not only improve postoperative recovery and reduce costs but also improve health status beyond postoperative period.
Non-randomized monocentric open cohort study vs historical comparative group testing the efficacy of a multimodal prehabilitation program for unfit patients based on nutrition, physical activity and mental preparation in reducing postoperative complications in elective major surgery.
Other outcomes will be measured : length of hospital stay, hospital readmissions, direct costs, health status at 1 and 6 months.
Moreover, the feasibility and adherence of Paprika program will be evaluated. Inter-data centres relating to the implementation of the same prehabilitation program will be compared with the consortium Paprika (Hospital Clinic of Barcelona, University of Cologne, University of Gdansk)
Study design
- Primary purpose
- Prevention
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Interventional group: Patients with Paprika program Historical group: Patients with same characteristics operated in 2018-2019
| Arm | Type | Receives |
|---|---|---|
| Paprika group | Experimental | Other: multimodal prehabilitationPatients coming for elective major surgery will participate to Paprika program |
| Historical group | No intervention | –Patients previously operated with same characteristics |
Who may qualify
- Ages
- 18 to 99 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- Patient eligible to elective major surgery (digestive, orthopedic, vascular-thoracic, urologic)
- Age > 70 years and/or American Society of Anesthesiologists (ASA) score 3-4
- or Unfit patient according to appropriate scores (Two among 3 scores (HAD, Physical activity score, nutritional score) below threshold). Unfit patients will be defined by at least 2 criteria if 'YES' answers: Physical activity: Less than 50% of WHO recommendations = less than 5000 steps/day or less than 75 min moderate activity/week or less than 12 min moderate activity/day Yes/No Malnutrition: BMI < 20 kg/m2 if < 70 years (or <22 if >70y) = undernutrition Yes/No or BMI>25 kg/m2 (= overweight to obesity) or Loss of appetite? Mental evaluation HAD (Hospital Anxiety and Depression) >8 for A or D score Yes/No
- Diagnosis:
- Elective major surgery (digestive, orthopedic, vascular-thoracic, urologic)
Key exclusion criteria (5 listed)
- Planned surgery (less than 4 weeks at inclusion)
- Urgent surgery
- Patient with, at baseline, good to excellent physical, nutritional, mental status as defined by appropriate scores.
- Patient considered not eligible to this program for physical or psychological reasons by the surgeon or the anesthetist
- Persons referred in Articles L1121-5 to L1121-8 of the French code of public health (this corresponds to all persons protected: pregnant or parturient women, breastfeeding mothers, persons deprived of liberty by judicial or administrative decision, persons subject to a legal protection measure).
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| multimodal prehabilitationPaprika prehabilitation program content: patients will have choices for each activity. Messages and motivation will be reinforced by using a mobile app or leaflet advices, according to patient's preferences. * Physical activity promotion by discovering ebike, personalised gymnastics and encouragement to increase the number of daily steps of patients, measured by a wristband and a mobile App * An individualized nutritional optimization plan with dietary advices and protein supplementation (if necessary). * Psychological support will be proposed through auto-hypnosis sensibilisation or management of stress with Cognitive Behavior Stress Management technics | Other | Paprika group |
Primary outcome
Rate of postoperative complications at Day-30
Time frame: at Day-30 post surgery
Rate of postoperative complications at Day-30 classified following the standards of the European Society of Anaesthesiology and European Society of intensive Care Medicine.
10 secondary outcomes
Number and severity of postoperative complications
Time frame: within 30 days post surgery
Length of stay (ICU and Hospital)
Time frame: within 30 days post surgery
Hospital readmission
Time frame: within 30 days post surgery
Direct cost
Time frame: interventional group: 1 month-cost before surgery+1 month-post surgery / Control group: 1 month-cost post-surgery
Physical activity health status
Time frame: a baseline, presurgery and 6 months post surgery
Nutritional health status
Time frame: at baseline, 1 month and 6 months
Psychological health status
Time frame: at baseline, 1 month and 6 months
Number of patient participation to program in relation to the number of eligible patients
Time frame: During Paprika inclusion period
Ratio patient participation to each session
Time frame: During Paprika 1 month-sessions
Comparison with other centers
Time frame: through study completion, an average of 1 year
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Apr 2021.
- Results publication: PubMed 28489682Barberan-Garcia A, Ubre M, Roca J, Lacy AM, Burgos F, Risco R, Momblan D, Balust J, Blanco I, Martinez-Palli G. Personalised Prehabilitation in High-risk Patients Undergoing Elective Major Abdominal Surgery: A Randomized Blinded Controlled Trial. Ann Surg. 2018 Jan;267(1):50-56. doi: 10.1097/SLA.0000000000002293.
- Results publication: PubMed 31248644Barberan-Garcia A, Ubre M, Pascual-Argente N, Risco R, Faner J, Balust J, Lacy AM, Puig-Junoy J, Roca J, Martinez-Palli G. Post-discharge impact and cost-consequence analysis of prehabilitation in high-risk patients undergoing major abdominal surgery: secondary results from a randomised controlled trial. Br J Anaesth. 2019 Oct;123(4):450-456. doi: 10.1016/j.bja.2019.05.032. Epub 2019 Jun 25.
- Individual participant dataSharing planned: Yes. Anonymised data will be shared with Barcelona, Köln and Gdansk: all collected IPD
Related trials for Urologic Diseases
RecruitingPhase 3
A Phase 3 Blinded Study of JADE101 in Participants With Immunoglobulin A Nephropathy
IgA Nephropathy (IgAN)
RecruitingPhase 2
A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
IgA Nephropathy
RecruitingPhase 2
A Clinical Trial of Extended (High) Treatment Dose Antibiotics in Combination With Methenamine Hippurate Compared to the Standard of Care (Either Prophylactic (Low) Dose Antibiotic Treatment or Methenamine Hippurate) in Females With Chronic Urinary Tract Infection
Chronic Urinary Tract Infection
RecruitingPhase 3
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
Urothelial Cancer, Urinary Bladder Neoplasms
Not yet recruitingPhase 1
Bioengineered Penile Tissue Constructs for Irreversibly Damaged Penile Corpora
Urologic Diseases, Male Urogenital Diseases
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Laura Albaladejo contact
Pierre Albaladejo, Prof. principal investigator
CHU Grenoble Alpes
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing multimodal prehabilitation in people with Urologic Diseases and Cardiovascular Diseases, run by University Hospital, Grenoble at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 30 Apr 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Marie-France Vaillant (+33 4 76 76 89 13, mfvaillant@chu-grenoble.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Rate of postoperative complications at Day-30 (time frame: at Day-30 post surgery). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04190719, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Apr 2021.